prednisolone has been researched along with Greater Tuberosity Fractures in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ochi, K | 1 |
| Furuya, T | 1 |
| Ishibashi, M | 1 |
| Watanabe, M | 1 |
| Ikari, K | 1 |
| Taniguchi, A | 1 |
| Yamanaka, H | 1 |
| Momohara, S | 1 |
1 other study available for prednisolone and Greater Tuberosity Fractures
| Article | Year |
|---|---|
Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures.
Topics: Adult; Age Factors; Aged; Arthritis, Rheumatoid; Biomarkers; Bone Density Conservation Agents; C-Rea | 2016 |